1.
Peachaphol Chongvoranond, Thewjitcharoen Y, Chatchomchuan W, Wanothayaroj E, Butadej S, Nakasatien S, et al. Sodium-Glucose Cotransporter-2 inhibitor (SGLT2i) Prescription Rates Amongst Diabetologists for Type 2 Diabetes Patients with Albuminuric Diabetic Kidney Disease:: A Real-World Study at a Diabetes Center in Bangkok. J ASEAN Fed Endocr Soc [Internet]. 2025 Nov. 13 [cited 2026 Apr. 24];40(2):69-77. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/5007